proxyvotesnow.com

Home › Asset managers › Fidelity › 2024-2025 › Against the board

Fidelity 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Fidelity voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

6,078 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.

Fidelity, 2024-2025 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedFidelity votedFunds
NAYA BIOSCIENCES INC. April 9, 2025 To elect five directors to the Board of Directors of the Company (the "Board"): Barbara Ryan Director Elections Board WITHHOLD 4
NAYA BIOSCIENCES INC. April 9, 2025 To elect five directors to the Board of Directors of the Company (the "Board"): Trent Davis Director Elections Board WITHHOLD 4
NETSOL TECHNOLOGIES INC. June 24, 2025 Approve the adoption of the 2025 Equity Incentive Plan Compensation Board AGAINST 4
NEUROONE MEDICAL TECHNOLOGIES CORP. February 14, 2025 Approval of the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan. Compensation Board AGAINST 4
NEUROONE MEDICAL TECHNOLOGIES CORP. February 14, 2025 Election of Class II Director: David Rosa Director Elections Board WITHHOLD 4
NEW WORLD DEVELOPMENT COMPANY LTD. November 21, 2024 Approve Grant of Mandate to the Directors to Grant Options Under the Share Option Scheme Compensation Board AGAINST 4
NEW WORLD DEVELOPMENT COMPANY LTD. November 21, 2024 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 4
NEXTERA ENERGY INC. May 22, 2025 Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement. Say-on-Pay Board (inferred) AGAINST 4
NICOLET BANKSHARES INC. May 19, 2025 Election of Directors: Donald J. Long, Jr. Director Elections Board WITHHOLD 4
NICOLET BANKSHARES INC. May 19, 2025 Election of Directors: Glen E. Tellock Director Elections Board WITHHOLD 4
NICOLET BANKSHARES INC. May 19, 2025 Election of Directors: John N. Dykema Director Elections Board WITHHOLD 4
NICOLET BANKSHARES INC. May 19, 2025 Election of Directors: Susan L. Merkatoris, MBA Director Elections Board WITHHOLD 4
NIHON M&A CENTER HOLDINGS INC. June 26, 2025 Elect Director and Audit Committee Member Abe, Mizuho Director Elections Board AGAINST 4
NISSAN CHEMICAL CORP. June 26, 2025 Appoint Statutory Auditor Kinugawa, Sachie Compensation Board AGAINST 4
NOVO INTEGRATED SCIENCES INC. November 22, 2024 Election of five directors: Alex Flesias Director Elections Board AGAINST 4
NOVO INTEGRATED SCIENCES INC. November 22, 2024 Election of five directors: Michael Pope Director Elections Board AGAINST 4
NRX PHARMACEUTICALS INC. October 8, 2024 Election of Class III Directors: Patrick J. Flynn Director Elections Board WITHHOLD 4
NSK LTD. June 25, 2025 Elect Director Hayashi, Nobuhide Director Elections Board AGAINST 4
NUTRIBAND INC. January 23, 2025 Adopt the Company's 2024 Amended and Restated Stock Option Plan Compensation Board AGAINST 4
NUTRIBAND INC. January 23, 2025 Election of Directors: Mark Hamilton Director Elections Board WITHHOLD 4
NXU INC. February 11, 2025 (the "Equity Plan Proposal") to approve the Verde Bioresins, Corp. 2025 Equity Incentive Plan, in the form attached to the accompanying proxy statement/prospectus as Annex C. Compensation Board AGAINST 4
NXU INC. February 11, 2025 (the "Transaction Proposal") to approve (i) the issuance of shares of Nxu common stock, which will represent more than 20% of the shares of Nxu common stock outstanding immediately prior to the Merger, to stockholders of Verde, pursuant to the terms of the Merger Agreement, a copy of which is attached to the accompanying proxy statement/prospectus as Annex A, and (ii) the change of control of Nxu resulting from the Merger, pursuant to Nasdaq Listing Rules 5635(a) and 5635(b), respectively. Extraordinary Transactions Board AGAINST 4
Nabors Industries Ltd. June 3, 2025 Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. Say-on-Pay Board AGAINST 4
OCEAN BIOMEDICAL INC. March 28, 2025 authorize the slate of directors: Chirinjeev Kathuria Director Elections Board WITHHOLD 4
OCEAN BIOMEDICAL INC. March 28, 2025 authorize the slate of directors: Elizabeth Ng Director Elections Board WITHHOLD 4
OCEAN BIOMEDICAL INC. March 28, 2025 authorize the slate of directors: Jonathan Kurtis Director Elections Board WITHHOLD 4
OCEAN BIOMEDICAL INC. March 28, 2025 authorize the slate of directors: Michael L. Peterson Director Elections Board WITHHOLD 4
ODDITY TECH LTD. November 13, 2024 Reelect Lilach Payorski as External Director and Approve Her Remuneration Director Elections Board AGAINST 4
ODDITY TECH LTD. November 13, 2024 Reelect Michael Farello as Director and Approve His Remuneration Director Elections Board AGAINST 4
ODDITY TECH LTD. November 13, 2024 Reelect Yehoshua (Shuki) Nir as Director and Approve His Remuneration Director Elections Board AGAINST 4
ONDAS HOLDINGS INC. November 18, 2024 Election of Directors: Jaspreet Sood Director Elections Board WITHHOLD 4
ONTRAK INC. September 10, 2024 To approve the Company's Amended and Restated 2017 Stock Incentive Plan. Compensation Board AGAINST 4
ONTRAK INC. September 10, 2024 To approve the Company's non-employee director retention plan. Compensation Board AGAINST 4
ONTRAK INC. September 10, 2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay Board AGAINST 4
OPAL FUELS INC. June 18, 2025 Election of Directors: Mark Comora, Chairman Director Elections Board WITHHOLD 4
OPTINOSE INC. May 16, 2025 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to our named executive officers in connection with the consummation of the merger. Say-on-Pay Board AGAINST 4
PARK24 CO. LTD. January 30, 2025 Elect Director and Audit Committee Member Nagasaka, Takashi Director Elections Board AGAINST 4
PARKER-HANNIFIN CORP. October 23, 2024 Approval of, on a non-binding, advisory basis, the compensation of our Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 4
PATRIOT NATIONAL BANCORP INC. June 26, 2025 Approval of the 2025 Omnibus Equity Incentive Plan. Compensation Board AGAINST 4
PATRIOT NATIONAL BANCORP INC. June 26, 2025 Approval of the Amended and Restated Certificate of Incorporation. Capital Structure Board AGAINST 4
PATRIOT NATIONAL BANCORP INC. June 26, 2025 Approval of the potential issuance of shares of common stock for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(d). Capital Structure Board AGAINST 4
PAX GLOBAL TECHNOLOGY LTD. May 21, 2025 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 4
PAX GLOBAL TECHNOLOGY LTD. May 21, 2025 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 4
PETRONET LNG LTD. January 25, 2025 Reelect Sanjeev Mitla as Director Director Elections Board AGAINST 4
PHARMACYTE BIOTECH INC. April 24, 2025 To elect five directors to serve one-year terms: Robert Weinstein Director Elections Board WITHHOLD 4
PICK N PAY STORES LTD. August 27, 2024 Re-elect Mariam Cassim as Member of the Audit, Risk and Compliance Committee Director Elections Board AGAINST 4
PIERIS PHARMACEUTICALS INC. December 11, 2024 To approve the adoption of the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan (as defined in this proxy statement/prospectus); Compensation Board AGAINST 4
PINEWOOD TECHNOLOGIES GROUP PLC June 30, 2025 Re-elect Bill Berman as Director Director Elections Board AGAINST 4
PINEWOOD TECHNOLOGIES GROUP PLC June 30, 2025 Re-elect Chris Holzshu as Director Director Elections Board AGAINST 4
PINEWOOD TECHNOLOGIES GROUP PLC June 30, 2025 Re-elect George Hines as Director Director Elections Board AGAINST 4
PINEWOOD TECHNOLOGIES GROUP PLC June 30, 2025 Re-elect Oliver Mann as Director Director Elections Board AGAINST 4
PLBY GROUP INC. June 16, 2025 An advisory, non-binding vote to approve the compensation of PLBY Group, Inc.'s named executive officers. Say-on-Pay Board AGAINST 4
PLBY GROUP INC. June 16, 2025 Election of Directors: Gyorgy Gattyan Director Elections Board WITHHOLD 4
PLBY GROUP INC. June 16, 2025 Election of Directors: Juliana F. Hill Director Elections Board WITHHOLD 4
PRO-DEX INC. November 21, 2024 Election of Directors: Nicholas J. Swenson Director Elections Board WITHHOLD 4
PROSUS NV August 21, 2024 Reelect Craig Enenstein as Director Director Elections Board AGAINST 4
PROSUS NV August 21, 2024 Reelect Roberto Oliveira de Lima as Director Director Elections Board AGAINST 4
PROTARA THERAPEUTICS INC. June 11, 2025 Approval of an Amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan Compensation Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Approve Remuneration Report Compensation Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Elect Hanne Myre as New Director Director Elections Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Reelect Arve Ree as Vice Chair Director Elections Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Reelect Else Bugge Fougner as Director Director Elections Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Reelect Jostein Sorvol as Director Director Elections Board AGAINST 4
PROTECTOR FORSIKRING ASA April 10, 2025 Reelect Jostein Sorvoll as Board Chair Director Elections Board AGAINST 4
PROYA COSMETICS CO. LTD. September 12, 2024 Elect Hou Yameng as Director Director Elections Board AGAINST 4
PROYA COSMETICS CO. LTD. September 12, 2024 Elect Jin Yanhua as Director Director Elections Board AGAINST 4
PROYA COSMETICS CO. LTD. September 12, 2024 Elect Ma Dongming as Director Director Elections Board AGAINST 4
PSYCHEMEDICS CORP. November 25, 2024 Approval of the amendment to our amended and restated certificate of incorporation to effect a reverse stock split of our common stock, at a ratio not less than 1-for-4,000 and not greater than 1-for-6,000 (the "Reverse Stock Split"), with the exact Reverse Stock Split ratio to be set within the foregoing range at the discretion of our Board. Capital Structure Board AGAINST 4
PSYCHEMEDICS CORP. November 25, 2024 Ratification of the terms and conditions of the Stock Purchase Agreement, dated August 12, 2024, by and among us, 3K Limited Partnership, Peter H. Kamin, the Peter H. Kamin Revocable Trust dated February 2003, the Peter H. Kamin Childrens Trust dated March 1997, the Peter H. Kamin GST Trust and the Peter H. Kamn Family Foundation and approval of the transactions contemplated thereby. Capital Structure Board AGAINST 4
PT ANEKA TAMBANG TBK June 12, 2025 Approve Annual Report, Financial Statements, Statutory Reports, Financial Statement of the Micro and Small Business Funding Program (PUMK) and Discharge of Directors and Commissioners Capital Structure Board AGAINST 4
PT ANEKA TAMBANG TBK June 12, 2025 Approve Changes in the Boards of the Company Director Elections Board AGAINST 4
PT BANK MANDIRI (PERSERO) TBK March 25, 2025 Approve Allocation of Income Capital Structure Board AGAINST 4
PT BANK MANDIRI (PERSERO) TBK March 25, 2025 Approve Remuneration and Tantiem of Directors and Commissioners Compensation Board AGAINST 4
PT INDAH KIAT PULP & PAPER TBK June 16, 2025 Approve Changes in the Boards of the Company Director Elections Board AGAINST 4
PULMATRIX INC. December 18, 2024 Election of Class I Directors: Todd Bazemore Director Elections Board WITHHOLD 4
PULMATRIX INC. June 16, 2025 Approval of the Cullgen Inc. 2025 Stock Incentive Plan. Compensation Board AGAINST 4
PULMATRIX INC. June 16, 2025 Approve the Cullgen Inc. 2025 Employee Stock Purchase Plan. Compensation Board AGAINST 4
PULTEGROUP INC. April 30, 2025 Shareholder proposal on adoption of Paris-aligned emission reduction goals, if properly presented at the meeting. Environment or Climate Shareholder Against FOR 4
Preformed Line Products Company May 13, 2025 To elect four directors, each for a term expiring in 2027: Richard R. Gascoigne Director Elections Board WITHHOLD 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - Arrangements for the Accumulated Undistributed Profit Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - Location of Listing Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - Lock-up Period Arrangements Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - Pricing Benchmark Date, Pricing Basis and Issue Price Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - Types and Par Value of Shares to be Issued Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - the Amount of Raised Ancillary Funds and the Number of Shares to be Issued Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - the Method of Issuance, Target Subscriber and Subscription Method Extraordinary Transactions Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Raising Ancillary Funds - the Use of Raised Ancillary Funds Capital Structure Board AGAINST 4
QINGDAO PORT INTERNATIONAL CO. LTD. September 13, 2024 Approve Validity Period of the Resolution Extraordinary Transactions Board AGAINST 4
QUALIGEN THERAPEUTICS INC. October 25, 2024 Election of directors: Campbell Becher Director Elections Board WITHHOLD 4
QUICK CO. LTD. June 20, 2025 Elect Director and Audit Committee Member Saito, Makoto Director Elections Board AGAINST 4
QXO INC. May 12, 2025 Advisory vote to approve executive compensation. Say-on-Pay Board AGAINST 4
RAVE RESTAURANT GROUP INC. December 10, 2024 Election of Directors: MARK E. SCHWARZ Director Elections Board WITHHOLD 4
RED CAT HOLDINGS INC. October 15, 2024 Election of five (5) Directors: Joseph Freedman Director Elections Board WITHHOLD 4
RED CAT HOLDINGS INC. October 15, 2024 Election of five (5) Directors: Nicholas Liuzza Jr. Director Elections Board WITHHOLD 4
RED CAT HOLDINGS INC. October 15, 2024 The approval of the 2024 Omnibus Equity Incentive Plan. Compensation Board AGAINST 4
REIT 1 LTD. December 23, 2024 Reappoint BDO Ziv Haft as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 4
REIT 1 LTD. December 23, 2024 Reelect Yekutiel Gavish as Director Director Elections Board AGAINST 4
RELMADA THERAPEUTICS INC. May 23, 2025 To approve an amendment to the Relmada Therapeutics, Inc. 2021 Equity Incentive Plan to increase the shares of our common stock available for issuance thereunder by 2.0 million shares. Compensation Board AGAINST 4
RELMADA THERAPEUTICS INC. May 23, 2025 To elect Class I director, to serve for a three-year term that expires at the Annual Meeting of Stockholders in 2028, or until her successor is elected and qualified or until her earlier resignation or removal: Fabiana Fedeli Director Elections Board WITHHOLD 4
RENEO PHARMACEUTICALS INC. September 26, 2024 To consider and vote upon a proposal to approve the 2024 Employee Stock Purchase Plan of NewCo; Compensation Board AGAINST 4

← Previous Page 49 of 61 Next →

← Back to Fidelity 2024-2025 overview

Built November 7, 2026 from SEC Form N-PX filings.